FDA Inspection 1207882 — Versiti Wisconsin, Inc

Versiti Wisconsin, Inc — FEI 2171378

The FDA completed an inspection of Versiti Wisconsin, Inc on April 26, 2023 in Milwaukee, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Milwaukee, WI (United States)